Table 2. Attributable burden on HRQoL in patients with onco-hematological disease: comparison with chronic tumors or diseases.
| Disease |
SF-12 score
Average±sd |
Attributable Burden on HRQoL |
Comparison with Onco-hematologic Disease
ANOVA 1 way |
p |
|---|---|---|---|---|
| Major Depression (N=37) |
33.8±9.2 | 5.6±3.6 | df 1,95,96 F=0.255 |
0.615 |
| Multiple Sclerosis (N=201) |
29.5± 7.3 | 7.0±3.5 | df 1,261,9262 F=4.673 |
0.032 |
| Wilson Disease (N=23) |
33.8±9.0 | 4.4±1.7 | df 1,83,84 F=5.623 |
0.020 |
| Carotidal atherosclerosis (N=46) |
30.6±8.1 | 6.2±5.0 | df 1,106,107 F=0.115 |
0.735 |
| Celiac disease (N=60) |
35.83±5.72 | 2.4±1.0 | df 1,120,121 F= 67.959 |
<0.00001 |
| Solid tumors (N=151) |
32.34±6.764 | 4.67±6.64 | df 1,211,212 F= 0.770 |
0.381 |
| Onco-hematological tumors (N=62) |
32.60±5.43 | 5.44±2.93 |